NASDAQ: FWBI
First Wave Bio

 

PRESS RELEASES
MEDIA

 

PRESS RELEASES

2022  
Title Date
First Wave BioPharma Announces Initial Clinical Sites for its Phase 2 Trial of Enhanced Microgranule Delivery Formulation of Adrulipase
05 December
First Wave BioPharma Files Investigational New Drug Application for Enhanced Microgranule Delivery Formulation of Adrulipase
30 November
First Wave BioPharma Announces Distribution of Series F Preferred Stock to Holders of Its Common Stock
25 November
First Wave BioPharma, Inc. Announces Closing of Private Placement
22 November
First Wave BioPharma, Inc. Announces Private Placement
21 November
First Wave BioPharma Chairman and CEO Issues Letter to Stockholders
16 November
First Wave BioPharma Engages Rho to Manage Phase 2 Clinical Trial of Enhanced Adrulipase Formulation
31 October
First Wave BioPharma, Inc. Announces Closing of $6.0 Million Public Offering
11 October
First Wave BioPharma Presents Research Demonstrating Benefits of Improved Adrulipase Drug Delivery Formulation at AAPS 2022 PharmSci 360
10 October
First Wave BioPharma, Inc. Announces Pricing of $6.0 Million Public Offering
06 October
First Wave BioPharma’s CEO James Sapirstein to Present at Inaugural Roth Healthcare Opportunities Conference
28 September
First Wave BioPharma Chairman and CEO Issues Letter to Stockholders
19 September
First Wave BioPharma CEO James Sapirstein to Moderate Panel Discussion at Longwood Healthcare Leaders Fall Webconference
14 September
First Wave BioPharma Finalizes Selection of Adrulipase Microgranule Drug Delivery Formulation
07 September
First Wave BioPharma Announces AAPS 2022 PharmSci 360 Accepts Adrulipase Formulation Abstract
31 August
First Wave BioPharma to Present at H.C. Wainwright 24th Annual Global Investment Conference 2022
29 August
First Wave BioPharma, Inc. Announces Reverse Stock Split
25 August
First Wave BioPharma, Inc. Announces Private Placement
15 July
First Wave BioPharma to Participate in “Fireside Chat” at the H.C. Wainwright Global Investment Conference
17 May
First Wave BioPharma Chairman and CEO Issues Letter to Shareholders
29 April
First Wave BioPharma Forms Clinical Steering Committee Focused on Advancing Inflammatory Bowel Disease (IBD) Product Portfolio
27 April
First Wave BioPharma Files U.S. and PCT Patent Applications for Niclosamide in Long-Haul COVID-19
28 March
First Wave BioPharma to Participate in Maxim’s 2022 Virtual Growth Conference
22 March
First Wave BioPharma to Participate in ”Fireside Chat” at the 34th Annual Roth Conference
08 March
First Wave BioPharma Announces Poster Presentation at the 2022 Digestive Disease Week (DDW) Conference
03 March
First Wave BioPharma, Inc. Announces Closing of $9 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
02 March
First Wave BioPharma Announces Appointment of Sarah Romano as Chief Financial Officer
01 March
First Wave BioPharma, Inc. Announces $9 Million Registered Direct Offering Priced At-The-Market Under NASDAQ Rules
28 February
First Wave BioPharma to Participate in the 2022 BIO CEO & Investor Conference
07 February
First Wave BioPharma Provides Update on Adrulipase (FW-EPI) Clinical Program
13 January
First Wave BioPharma Announces Further Adjournment of Annual Meeting
07 January
First Wave BioPharma Completes Enrollment for Part 2 of RESERVOIR Phase 2 Trial Evaluating FW-COV in COVID-19-Related GI Infections
06 January
First Wave BioPharma to Participate in Two Investor Conferences in January 2022
04 January

 

2021

 

2020

 

2019

 

2018

 

2017

 

2016

 

2015

 

2014

 

MEDIA

2022

TitleFormatDate
Life Science Leader magazine interviews James Sapirstein Article 01 December
Impact Wealth: Impacting The BioPharma Industry With James Sapirstein Article 04 November
Fierce Biotech: First Wave signs up Rho for phase 2 trial of gastrointestinal drug Article 03 November
Cystic Fibrosis News Today: First Wave, Rho Team Up to Test New Adrulipase Treatment for CF Article 02 November
The Top 100 Innovators and Entrepreneurs Magazine Interviews James Sapirstein Article 25 October
Toni Loudenbeck of Traders News Source Interviews James Sapirstein CEO, First Wave BioPharma, Inc. Audio 6 October
Clinical Trial Guru interviews James Sapirstein Video 23 September
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 08 September
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 30 August
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 14 June
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 29 April
Medscape Education Issues Presentation on: “The Gastrointestinal System and COVID-19” Presentation 22 April
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 01 April
Global Business Reports – interview with James Sapirstein Article 22 March
BioTuesdays – First Wave developing targeted, non-systemic therapies for GI diseases Article 22 March
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 01 March
U.S. Pharmaceutical Industry Newsletter Article 18 February
Health Professional Radio: “Phase 2 RESERVOIR Study for COVID-GI Symptoms"  Podcast  09 February 
Health Professional Radio: “Phase 2 RESERVOIR Study for COVID-GI Symptoms"  Podcast  09 February 
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein  Video  27 January 
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein  Video  19 January 
New to the Street: Jane King Interviews James Sapirstein  Video  17 January 
The Bio Report – Repurposing A Drug For Parasitic Infections As A Targeted GI Therapy  Podcast  13 January 
First Wave BioPharma Files Two Provisional US Patent Applications For Adrulipase – Benzinga  Article  13 January 
EXCLUSIVE: First Wave BioPharma CEO Talks COVID-19 Trial – Benzinga  Article/Video  06 January 
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein  Video 06 January 
2021

TitleFormatDate
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 02 December 
The Clinical Research Circle – Dan Sfera interviews James Sapirstein Video 19 October 
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 12 October 
New to the Street: Jayne King interviews James Sapirstein Video 01 October 
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 28 September 
AzurRx to Acquire First Wave Bio for $229m Article 14 September 
AzurRx Carves Out Slice of IBD Market in $229 Million Buyout | BioSpace Article 13 September 
AzurRx boosts GI pipeline through First Wave buyout worth up to $229M | FierceBiotech Article 13 September 
Serial entrepreneur Gary Glick sells another one of his startups for $290M — this time to an unlikely buyer – Endpoints News (endpts.com) Article 13 September 
AzurRx BioPharma Acquires First Wave Bio Inc. - Contract Pharma Article 13 September 
AzurRx Carves Out Slice of IBD Market in $229 Million Buyout Article 13 September 
AzurRx boosts GI pipeline through First Wave buyout worth up to $229M Article  13 September
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 07 September 
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 12 August 
The Big Biz Show – Bob “Sully” Sullivan interviews James Sapirstein Video 26 July 
National Public Radio (NPR) – KERA: Sam Baker interviews AzurRx COVID-GI clinical trial principal investigator Dr. Salma Saiger – “It’s Not Just A Respiratory Disease: How COVID Can Impact Your Gut” Podcast 19 July 
The Clinical Trials Guru – with Dan Sfera and James Sa Video 09 July 
Enhancing Human Life – with James Sapirstein and James Pennington Video 22 June 
New to the Street Video 13 June 
Healthcheck (WFAA-ABC Dallas/Ft. Worth): Sonia Azad discusses COVID-GI infections and the AzurRx Reservoir clinical trial with Dr. Salma Saiger Video 10 June 
The Big Biz ShowThe Big Biz Show - Bob “Sully” Sullivan interviews James Sapirstein Video 10 June 
Enhancing Human Life - with James Sapirstein and Douglas Jensen Video 9 June
Enhancing Human Life - with James Sapirstein and Douglas Jensen Podcast 9 June
WBAP/KLIF Dallas: Katrina Boonzaier interviews Dr. Salma Saiger about COVID-GI infections and the initiation of AzurRx’s Reservoir clinical trial. Article 4 June
The Big Biz Show - Bob “Sully” Sullivan interviews James Sapirstein Video 17 May
Investor Summit Group Q2 Virtual Summit Video 17 May
New to the Street Video  14 May
The Big Biz Show Video 3 May
Global Business Reports Article 24 March
H.C. Wainwright Fireside Chat Video 22 March
The Fly Article 15 March
Health Professional Radio: “COVID-19 Infections of the GI Tract and the Long Haul Phenomenon” Podcast 8 March
Attacking COVID-19 Virus Hiding in the Gastrointestinal Tract of Long-Haulers with James Sapirstein AzurRx BioPharma on Empowered Patient Podcast with Karen Jagoda Podcast 15 February

 
2020

TitleFormatDate
 Newsmax ” National Report” with Shaun Kraisman & Emma Rechenberg  Video  30 December 
 Newsmax “American Agenda” with Bob Sellers  Video 29 December 
 Stock2Me Podcast Featuring AzurRx Biopharma Inc. President & CEO James Sapirstein   Podcast 24 November 
 NTD “America is Talking” with Cindy Drukier  Video  12 November 
 TD Ameritrade Network “The Watch List” with Shawn Cruz   Video 02 November 
The Richmond Club Video 20 June
U.S. Biopharmaceuticals 2020 Report Article 4 June
Stock News Now (SNN) Live Video 19 May
Innovators with Jane King (LilaMax Media) Video 18 May
AzurRx Biopharma in the Age of COVID-19 - Q&A with CEO James Sapirstein - April 21, 2020 Video 21 April
logo ICO

CONTACT

777 Yamato Road Suite 502
Boca Raton, FL 33431
(561) 589-7020
info@firstwavebio.com

SOCIAL MEDIA